Goodwill and Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets

Schedule of changes in the carrying amount of goodwill

(In thousands)	Generic Pharmaceuticals
Balance at June 30, 2017	$	339,566
Goodwill acquired	—
Impairments	—
Balance at September 30, 2017	$	339,566

Summary of intangible assets, net

	Weighted	Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	Avg. Life (Yrs.)	September 30, 2017		June 30, 2017		September 30, 2017			June 30, 2017			September 30, 2017		June 30, 2017
Definite-lived:
Cody Labs import license	15	$	582	$	582	$	(357	)	$	(347	)	$	225	$	235
KUPI product rights	15	434,000		434,000		(50,519		)	(43,286		)	383,481		390,714
KUPI trade name	2	2,920		2,920		(2,703		)	(2,338		)	217		582
KUPI other intangible assets	15	19,000		19,000		(2,345		)	(2,028		)	16,655		16,972
Silarx product rights	15	10,000		10,000		(1,556		)	(1,389		)	8,444		8,611
Other product rights	15	2,691		653		(365		)	(355		)	2,326		298
Total definite-lived		$	469,193	$	467,155	$	(57,845	)	$	(49,743	)	$	411,348	$	417,412
Indefinite-lived:
KUPI in-process research and development	—	$	18,000	$	18,000	$	—		$	—		$	18,000	$	18,000
Silarx in-process research and development	—	18,000		18,000		—			—			18,000		18,000
Other product rights	—	449		449		—			—			449		449
Total indefinite-lived		36,449		36,449		—			—			36,449		36,449
Total intangible assets, net		$	505,642	$	503,604	$	(57,845	)	$	(49,743	)	$	447,797	$	453,861

Summary of future annual amortization expense

(In thousands) Fiscal Year Ending June 30,	Amortization Expense
2018	$	23,530
2019	31,082
2020	31,074
2021	31,074
2022	31,074
Thereafter	263,514
	$	411,348